MedTrace Logo

Biomarkers in Inflammatory Rheumatic Diseases Diagnosis

NCT06778343 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2025-01-20

No results posted yet for this study

Summary

Ankylosing spondylitis (AS), Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are three diseases where early diagnosis remains a major challenge. However, early diagnosis is the main determinant for a better prognosis. In the early stage, symptoms may be nonspecific and often difficult to establish a differential diagnosis between rheumatic diseases and other diseases, namely infectious and cancer diseases.

Conditions

Sponsors & Collaborators

  • Centro Hospitalar Lisboa Ocidental Hospital Egas Moniz

    collaborator UNKNOWN

  • Universidade Nova de Lisboa

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2025-03-31
Completion
2025-06-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06778343 on ClinicalTrials.gov